West Virginia
Requires Coverage of Comprehensive Biomarker Testing
No
Highlighted Disparity
No racial disparities were found in West Virginia for these lung cancer metrics
Lung Cancer Rates
New Cases:
- The rate of new lung cancer cases in West Virginia is 76.3 and significantly higher than the national rate of 52.8.
- It ranks 50th among all states, placing it in the bottom tier.
- Over the last five years, the rate of new cases in West Virginia did not change significantly.
- In 2022, the most recent year of data available for this report, the COVID-19 pandemic continued to disrupt access to medical care, including delays and reductions in cancer diagnoses and screening. This led to a decline in incidence rates for most cancers, including lung cancer, and should not be interpreted as a reduction in the underlying cancer burden.
5-Year Survival Rate:
- The percent of people alive five years after being diagnosed with lung cancer in West Virginia is 25.5%, which is significantly lower than the national rate of 29.7%.
- It ranks 33rd among the 39 states with survival data, placing it in the below average tier.
- Over the last five years, the survival rate in West Virginia improved by 27%.
Early Diagnosis:
- In West Virginia, 28.4% of cases are caught at an early stage, which is not significantly different than the national rate of 28.1%.
- It ranks 25th among the 50 states with data on diagnosis at an early stage, placing it in the average tier.
- Over the last five years, the early diagnosis rate in West Virginia improved by 13%.
Lung Cancer Treatment
Biomarker Coverage:
- West Virginia has yet to require any insurance coverage of comprehensive biomarker testing, including for lung cancer, as of August 2025.
Surgical Treatment:
- West Virginia ranked 21st (out of the 49 states with available data) with 20.7% of cases undergoing surgery as part of the first course of treatment.
- This is not significantly different than the national rate of 20.7% and puts West Virginia in the average tier.
- Over the last five years, the percent of cases undergoing surgery in West Virginia did not change significantly.
No Treatment:
- West Virginia ranked 38th (out of the 49 states with available data) with 23.6% of cases not receiving any treatment.
- This is significantly higher than the national rate of 21.0% and puts West Virginia in the average tier.
- Over the last five years, the percent of cases receiving no treatment in West Virginia did not change significantly.
Screening
Screening for High Risk:
- In West Virginia, 15.4% of those at high risk were screened, which was not significantly different than the national rate of 18.2%.
- It ranks 38th among all states, placing it in the below average tier.
- Screening rates in this year’s report have been updated to correct an error in the data source and should not be compared to previous reports.
Prevention
Tobacco Use:
- The 2023 smoking rate in West Virginia is 20.4% and significantly higher than the national rate of 11.4%.
- It ranks 51st among all states, placing it in the bottom tier.
Radon Exposure:
- In West Virginia, 28.5% of radon tests results were at or above the action level recommended by EPA.
- It ranks 31st among all states, placing it in the average tier.
Racial & Ethnic Disparities
Black individuals:
- The rate of new lung cancer cases is 64.4 per 100,000 population among Black individuals in West Virginia, significantly higher than the rate of 54.2 among Black individuals nationally, and significantly lower than the rate of 77.6 among white individuals in West Virginia.
- The five-year survival rate is 25.8% among Black individuals in West Virginia, not significantly different than the rate of 27.1% among Black individuals nationally, and not significantly different than the rate of 25.5% among white individuals in West Virginia.
- 31.1% of lung cancer cases are diagnosed at an early stage among Black individuals in West Virginia, not significantly different than the rate of 25.1% among Black individuals nationally, and not significantly different than the rate of 28.4% among white individuals in West Virginia.
- 22.5% of Black individuals with lung cancer in West Virginia underwent surgery, not significantly different than the rate of 17.1% among Black individuals nationally, and not significantly different than the rate of 20.6% among white individuals in West Virginia.
- 20.5% of Black individuals with lung cancer in West Virginia did not receive any treatment, not significantly different than the rate of 22.7% among Black individuals nationally, and not significantly different than the rate of 23.7% among white individuals in West Virginia.
Latino individuals:
- Lung cancer rates are not available for Latino individuals in West Virginia due to too few cases over the time period to allow for accurate analysis.
Asian or Pacific Islander individuals:
- The rate of new lung cancer cases is 29.7 per 100,000 population among Asian or Pacific Islanders individuals in West Virginia, not significantly different than the rate of 32.5 among Asian or Pacific Islanders individuals nationally, and significantly lower than the rate of 77.6 among white individuals in West Virginia.
- State-level survival rates are not available for Asian or Pacific Islander individuals at this time. Nationally, the five-year survival rate among Asian or Pacific Islander individuals is 28.6% and significantly higher than the rate of 25.0% among white individuals.
- Other lung cancer rates are not available for Asian or Pacific Islander individuals in West Virginia due to too few cases over the time period to allow for accurate analysis.
Indigenous Peoples:
- Lung cancer rates are not available for Indigenous Peoples (American Indians/Alaska Natives) in West Virginia due to too few cases over the time period to allow for accurate analysis.
Summary
Despite the early diagnosis rate in West Virginia falling into the average tier, the state still has a lot of work to do to make sure that more of those at high risk for lung cancer are screened.
West Virginia has yet to require any insurance coverage of comprehensive biomarker testing, which can help determine what treatment options would be best for individuals with lung cancer and other diseases.
West Virginia falls into the average tier for percent of patients receiving no treatment. Some patients do refuse treatment, but issues such as fatalism and stigma can prevent eligible patients from accessing treatment that may save or extend their lives. All patients should work with their doctors to establish a treatment plan and goals.
Page last updated: October 29, 2025
